Preparation method for (2'R)-2'-deoxy-2'-fluoro-2'-methyluridine
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- NINGBO CHEMGOO PHAMA TECH
- Publication Date
- 2015-06-17
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
Technical field
[0001] The invention belongs to the technical field of organic chemistry, and relates to a preparation method of (2'R)-2'-deoxy-2'-fluoro-2'-methyluridine. Background technique
[0002] (2'R)-2'-deoxy-2'-fluoro-2'-methyluridine (Formula V) is the key intermediate of Sofosbuvir, a drug for the treatment of chronic hepatitis C virus (HCV) infection. The traditional literature preparation method is mainly to protect the fluororibose (formula I) as the starting material, after reductive acylation, and then with the TMS derivative of N-benzoylcytosine (formula II) to produce Protect cytidine (formula III), protect cytidine (formula III) and then undergo high-temperature hydrolysis to obtain dibenzoyl uridine (formula IV), and then deprotect the dibenzoyl uridine (formula IV) to obtain the target product urea Glycoside (Formula V) (Document 1: J. Med. Chem. 2010, 53, 7202-7218; Document 2: J. Med. Chem. 2005, 48, 5504-5508). The reaction formula is as follows
[0003] ...